Annals of Family Medicine
NOVEMBER 20, 2024
Despite efforts to improve patient-clinician relationships, access to care, and healthcare workflows, annual rates of missed appointments (MA) in the U.S Population Studied Adult patients scheduled for in-person or telehealth visits between 01/2019-06/2023. remain between 15-30%, costing $150 billion annually.
Annals of Family Medicine
NOVEMBER 20, 2024
Objective: To measure the impact on healthcare system utilization of an intensive primary care (IPC) service from 2019 through 2022. Few studies of high-utilization patient programs found improvements in the intervention groups compared to controls.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Clinical Problem Solvers
OCTOBER 18, 2022
Incarceration negatively affects the physical and mental health of people who are incarcerated as well as their family members and loved ones, and limits access to healthcare before, during, and after incarceration. All healthcare professionals will have patients who are directly or indirectly impacted by the carceral system.
Today's Hospitalist
MAY 9, 2025
By removing the need to constantly look at a screen or type notes, we can be more present and engaged, fostering stronger therapeutic relationships and improving patient satisfaction. Clinician burnout and its impact on healthcare delivery: A narrative review. Healthcare (Basel). Mayo Clin Proc. 2022;97(7):1307-1315.
FDA Law Blog
OCTOBER 14, 2021
FDA issued the same type of warning regarding RAS devices and mastectomy back in February 2019 suggesting that FDA believes the problem has persisted. Thus, this part of the Act becomes that much more important to healthcare providers innovating in the field of medicine. 21 U.S.C. §
FDA Law Blog
JANUARY 6, 2022
Note that EKRA’s reach is broader than the Anti-Kickback Statute, which applies only to “federal healthcare programs” — e.g., Medicare, Medicaid, Tricare, etc. S&G Labs has no contractual relationships with the entities that referred clients to S&G Labs. 18 U.S.C. § 24(b) (emphasis added). 18 U.S.C. § EKRA Issue.
FDA Law Blog
JANUARY 6, 2022
Note that EKRA’s reach is broader than the Anti-Kickback Statute, which applies only to “federal healthcare programs” — e.g., Medicare, Medicaid, Tricare, etc. S&G Labs has no contractual relationships with the entities that referred clients to S&G Labs. 18 U.S.C. § 24(b) (emphasis added). 18 U.S.C. § EKRA Issue.
Expert insights. Personalized for you.
130 
Let's personalize your content